Acute Hemodynamic Changes after Single Administration of Udenafil in Pulmonary Arterial Hypertension: a Phase IIa Study

BACKGROUND AND OBJECTIVES: Udenafil, a new phosphodiesterase-5 inhibitor (PDE5i), has been used to treat erectile dysfunction. Given the proven benefit of PDE5i in pulmonary arterial hypertension (PAH), we evaluated serial hemodynamic changes after single udenafil administration to determine the app...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Sung-A, Kim, Hyung-Kwan, Chang, Hyuk Jae, Kim, Duk-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428952/
https://www.ncbi.nlm.nih.gov/pubmed/30808080
http://dx.doi.org/10.4070/kcj.2018.0281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428952/
https://www.ncbi.nlm.nih.gov/pubmed/30808080
http://dx.doi.org/10.4070/kcj.2018.0281

Ejemplares similares